|Daily Range||$2.59 - $2.78|
|52-Week Range||$2.41 - $6.40|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||1,904,188|
|Current FY EPS||-$1.24|
Fourth-quarter earnings were nothing to get excited about, but the Contrave launch trajectory looks good so far.
Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog
Vivus Inc shares tanked today following results that failed to impress.